The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
about
New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsThe safety of cruciferous plants in humans: a systematic reviewCombined effects of aerobic exercise and diet on lipids and lipoproteins in overweight and obese adults: a meta-analysisThe effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012Electrical stimulation for treating pressure ulcersInfraorbital nerve block for postoperative pain following cleft lip repair in childrenOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illnessAntihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individualsCorticosteroids for the management of cancer-related pain in adultsOral nonsteroidal anti-inflammatory drugs for neuropathic painTests to assist in the diagnosis of keratinocyte skin cancers in adults: a generic protocolTests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocolHeat acclimation for protection from exertional heat stressAnalgesics for postoperative pain after tonsillectomy and adenoidectomy in childrenBuprenorphine for neuropathic pain in adultsPharmacological interventions for pain in children and adolescents with life-limiting conditionsCorticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemo- or radiotherapy, or surgery)Trigger point manual therapy for the treatment of chronic non-cancer pain in adultsThe effectiveness and cost-effectiveness of inpatient specialist palliative care in acute hospitals for adults with advanced illness and their caregiversAntihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individualsExtracorporeal shock wave therapy for the healing and management of venous leg ulcersAs required versus fixed schedule analgesic administration for postoperative pain in childrenAs required versus fixed schedule analgesic administration for postoperative pain in childrenOxycodone for neuropathic pain and fibromyalgia in adultsPsychological therapies for frequent episodic and chronic tension-type headache in adultsWheat flour fortification with iron for reducing anaemia and improving iron status in populationsBreastfeeding for procedural pain in infants beyond the neonatal periodAcupuncture for myofascial painEarly palliative care for improving quality of life and survival time in adults with advanced cancerInfraorbital nerve block for postoperative pain following cleft lip repair in childrenVenlafaxine for neuropathic painExercise for cancer cachexia in adultsCorticosteroids for the management of cancer-related pain in adultsPharmacological interventions for pain for life-limiting conditions in children and adolescentsOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illnessNeedle size for vaccination procedures in children and adolescentsOxycodone for neuropathic pain and fibromyalgia in adultsNon-fluoride topical remineralising agents containing calcium and/or phosphate for controlling dental cariesAcupuncture for myofascial painOral nonsteroidal anti-inflammatory drugs for neuropathic pain
P2860
Q21132464-A5235417-BA91-4B5A-8449-57A1A83D4CF3Q21285050-23F903BE-A250-4CC2-81E2-8C8E734F7CAEQ21285127-6F4B4170-654F-488B-9FC8-2834D110C4BFQ22252985-16DAB2AB-E9AF-4D52-B78B-9E97368EB597Q24185812-48C80ACC-9B73-49F6-AA53-B52F7DAAB4C7Q24185906-E0014466-64A7-42F7-9C36-277252B15CD6Q24185994-BBFA30CD-11B9-4FBB-B055-D6048F15B4C7Q24186039-B9311B64-7987-4F6B-BA66-056A8A2E96F6Q24186400-AECEF956-68ED-4CE6-BF85-4937A9D64561Q24186621-1989ABE9-92A9-4E2C-85BD-5A1CFFB5912CQ24186708-653D2E01-2EB3-469F-820A-B39E5CB44830Q24186719-C108AA95-4587-4545-8DB2-71C8F3C0D18EQ24186816-8828DDE4-1933-468F-9883-0AEBF7B56713Q24186898-A117A1C8-C08F-46D9-B769-7585AD7B6D91Q24186924-70002156-77E9-4D4A-A4D4-A8600A7501DBQ24187283-7396DB75-AE8C-410B-AF72-8A9BF9BA1CE9Q24187427-5756DBD0-876F-43B3-AFA2-E0C0EE38763BQ24187491-51293418-66F6-44F1-9680-765D5B42B927Q24187525-9D8F244F-157E-4183-8D86-EE67E45B513BQ24187556-EF5119D9-E591-4A21-B9B6-5C7E35B147B4Q24187635-635FA72D-2DEA-489D-9C83-54EEAC8C4E61Q24187943-909808D5-5A9B-49B6-B4C9-CA081A95DCD5Q24188165-C561FA81-2890-45C1-99C7-6A8861F11EF6Q24193845-3E56FCA3-1238-45F9-8D0A-2B18F1249717Q24193934-94581C80-14E8-43A7-A058-8377D02FAEFBQ24194086-B6F94DF4-1E18-44A9-8546-309973ADF34EQ24194610-5804E664-BCA4-4129-9AC7-EACD5D21F167Q24194696-723EBE15-2502-4FEE-BE7E-32CCEA5C5D8AQ24194817-2E2128B7-3E2F-4ACF-9F83-252E94F3BBB8Q24194823-0A19973F-1442-43CF-BB8D-2D7C40DE8A4BQ24197560-D7D80AED-A2BA-45AC-B1B9-4890CEA54A52Q24197733-E85DD061-4DFA-402B-9333-1D752EB1F0DAQ24197861-9E984226-C426-4043-A92F-3D84A330E505Q24198796-F8ACFF0E-581E-4175-B4A5-004EDB845D7CQ24199000-24D7669B-BA3B-42B5-8ABC-6697B981A0A0Q24200692-6E244804-68A7-4785-BF1F-01EE25AE6676Q24200889-94048869-63E3-44E0-B43F-02D43A482347Q24201628-D7958F1F-993C-4950-929B-CF8654D83EE5Q24201715-4AB1C960-7E1D-420A-8208-4CCA8949ED85Q24202080-AA7D6E60-F085-4B36-A0FB-8DDA92FC7CA2
P2860
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The PRISMA statement for repor ...... s: explanation and elaboration
@en
The PRISMA statement for repor ...... s: explanation and elaboration
@nl
type
label
The PRISMA statement for repor ...... s: explanation and elaboration
@en
The PRISMA statement for repor ...... s: explanation and elaboration
@nl
prefLabel
The PRISMA statement for repor ...... s: explanation and elaboration
@en
The PRISMA statement for repor ...... s: explanation and elaboration
@nl
P2093
P50
P3181
P1476
The PRISMA statement for repor ...... s: explanation and elaboration
@en
P2093
Cynthia Mulrow
Jos Kleijnen
Mike Clarke
P J Devereaux
P304
P3181
P356
10.7326/0003-4819-151-4-200908180-00136
P407
P50
P577
2009-08-18T00:00:00Z